Here are the latest quarterly results of LAURUS LABS . For more details, see the LAURUS LABS financial fact sheet and LAURUS LABS share price. For a sector overview, read our pharmaceuticals sector report.
| No. of Mths Qtr. Ending |
3
Jun-24* |
3
Sep-24* |
3
Dec-24* |
3
Mar-25* |
3
Jun-25* |
3
Sep-25* |
3
Dec-25* |
3
Mar-26* |
8-Qtr Chart Click to enlarge |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | Rs m | 11,949 | 12,237 | 14,151 | 17,203 | 15,696 | 16,535 | 17,783 | 18,116 | |
| Other income | Rs m | 25 | 46 | 94 | 586 | 104 | 270 | 58 | 118 | |
| Turnover | Rs m | 11,974 | 12,283 | 14,245 | 17,789 | 15,800 | 16,804 | 17,841 | 18,234 | |
| Expenses | Rs m | 10,237 | 10,454 | 11,299 | 12,997 | 11,874 | 12,502 | 12,981 | 12,995 | |
| Gross profit | Rs m | 1,712 | 1,783 | 2,852 | 4,206 | 3,821 | 4,033 | 4,802 | 5,121 | |
| Depreciation | Rs m | 1,061 | 1,075 | 1,061 | 1,104 | 1,168 | 1,205 | 1,206 | 1,221 | |
| Interest | Rs m | 492 | 526 | 578 | 564 | 515 | 400 | 388 | 404 | |
| Profit before tax | Rs m | 185 | 228 | 1,307 | 3,123 | 2,242 | 2,697 | 3,266 | 3,614 | |
| Tax | Rs m | 63 | 51 | 401 | 785 | 631 | 760 | 735 | 795 | |
| Profit after tax | Rs m | 122 | 177 | 906 | 2,339 | 1,611 | 1,938 | 2,531 | 2,819 | |
| Gross profit margin | % | 14.3 | 14.6 | 20.2 | 24.4 | 24.3 | 24.4 | 27.0 | 28.3 | |
| Effective tax rate | % | 33.9 | 22.3 | 30.7 | 25.1 | 28.2 | 28.2 | 22.5 | 22.0 | |
| Net profit margin | % | 1.0 | 1.4 | 6.4 | 13.6 | 10.3 | 11.7 | 14.2 | 15.6 | |
| Diluted EPS | Rs | 0.2 | 0.3 | 1.7 | 4.3 | 3.0 | 3.6 | 4.7 | 5.2 | |
| Diluted EPS (TTM) | Rs | 2.8 | 2.4 | 3.6 | 6.6 | 9.3 | 12.6 | 15.6 | 16.5 | |
Asian markets declined on Monday, 13 July, as investor sentiment remained focused on rising tensions in the Middle East after the United States and Iran carried out fresh military strikes over the weekend, while Tehran announced the closure of the Strait of Hormuz.